NCT03249064View on ClinicalTrials.gov

Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

October 27, 2015

Primary Completion Date

September 13, 2016

Study Completion Date

September 13, 2016

Conditions
VITILIGO
Interventions
DIAGNOSTIC_TEST

CD 91 levels

DIAGNOSTIC_TEST

Tregs

Trial Locations (1)

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT03249064 - Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo | Biotech Hunter | Biotech Hunter